M
Marta Pastor
Researcher at University of the Basque Country
Publications - 19
Citations - 700
Marta Pastor is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Solid lipid nanoparticle & Pseudomonas aeruginosa. The author has an hindex of 12, co-authored 19 publications receiving 568 citations.
Papers
More filters
Journal ArticleDOI
A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.
Garazi Gainza,Marta Pastor,José Javier Aguirre,Silvia Villullas,José Luis Pedraz,Rosa Maria Hernandez,Manoli Igartua +6 more
TL;DR: The in vitro experiments demonstrated that gamma sterilisation is a suitable process for the final sterilisation because no loss in activity was observed after the sterilisation process and the proliferation assays revealed that the bioactivity of the nanoformulations was even higher than that of free rhEGF.
El Sistema Internacional de Imágenes Afectivas (IAPS): Adaptación Española. Segunda parte
Jaime Vila Castellar,María Blasa Sánchez,Isabel Ramírez Uclés,María del Carmen Fernández Santaella,María Pilar Cobos Alvarez,Sonia Fernandez,Miguel Ángel Muñoz García,María Pilar Tormo Irún,María José Herrero,Pilar Segarra Cabedo,Marta Pastor,Susana Montañes Martí,Rosario Poy Gil,Javier Moltó +13 more
TL;DR: This article presented the valores normativos de la adaptación espanola de los conjuntos 9-14 (segunda parte) del International Affective Picture System (IAPS).
Journal ArticleDOI
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
TL;DR: This review aims at gathering together the novel nanosystems for anti-infectious therapy, underlining the potential of DDSs to improve and optimize currently available antibiotic therapies in the context of lung infections.
Journal ArticleDOI
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis
Marta Pastor,María Moreno-Sastre,A. Esquisabel,Eulàlia Sans,Miguel Viñas,Daniel Bachiller,Víctor J. Asensio,Ángel Del Pozo,Eusebio Gainza,José Luis Pedraz +9 more
TL;DR: In vivo distribution experiment showed that nanoparticles spread homogenously through the lung and there was no migration of lipid nanoparticles to other organs, such as liver, spleen or kidneys, which appeared to be less toxic than free sodium colistimethate in cell culture.
Journal ArticleDOI
Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients
Eulàlia Sans-Serramitjana,Ester Fusté,Blanca Martínez-Garriga,Alexandra Merlos,Marta Pastor,José Luis Pedraz,A. Esquisabel,Daniel Bachiller,Teresa Vinuesa,Miguel Viñas +9 more
TL;DR: Colistin nanoparticles had the same antimicrobial activity as free drug against planktonic bacteria, however, nanoencapsulated colistin was much more efficient in the eradication of biofilms than free colistins, and have to be considered as a good alternative therapeutic option to treat P. aeruginosa infections.